AVTR Avantor, Inc.
NYSE · SEC CIK 1722482 · EDGAR
- Bought, last 12 months
- $8.69M 8 purchases by 5 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 272 since 2021-07-13, latest 2026-09-23 16:30
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| MEHRA SANJEEV K | Dir | $4.88M | — |
| SUMME GREGORY L | Dir | $2.06M | — |
| Ligner Emmanuel | Pres, CEO, Dir | $993.1K | — |
| LUCIER GREGORY T | Dir | $541.2K | — |
| Dingemans Simon | Dir | $203.5K | — |
| Brellier Ludovic | EVP, Bioscience, Medtech | — | — |
| Blenn Mary | EVP, COO | — | — |
| Makin Louise | Dir | — | — |
| Gourdier Benoit | EVP, Bioscience, Medtech | — | — |
| Hankamer Brittany | EVP, Chief HR Off | — | — |
Transactions 328
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-05 | 2022-01-03 | AVTR | Brophy Gerard | EVP, Biopharma Production | M - OptEx | $18.45 | +59.4K | 202.3K | +42% | +$1.10M |
| 2022-01-05 | 2022-01-02 | AVTR | Vanderhaegen Frederic | EVP, Europe | F - Tax | $42.14 | -1,017 | 153.5K | -0.7% | -$42.9K | |
| 2022-01-03 | 2021-12-31 | AVTR | Lewis Sheri | EVP, Gbl Ops, Supply Chain | F - Tax | $42.14 | -4,093 | 62.8K | -6% | -$172.5K | |
| 2022-01-03 | 2021-12-31 | AVTR | Henson Meghan | EVP, Chief HR Off | F - Tax | $42.14 | -1,877 | 24.0K | -7% | -$79.1K | |
| D | 2021-12-28 | 2021-12-27 | AVTR | Couturier Christophe | EVP, AMEA | M - OptEx | $23.21 | +10.2K | 120.7K | +9% | +$236.4K |
| D | 2021-12-28 | 2021-12-27 | AVTR | Couturier Christophe | EVP, AMEA | S - Sale+OE | $41.63 | -10.2K | 110.5K | -8% | -$424.0K |
| DM | 2021-12-23 | 2021-12-21+ | AVTR | Couturier Christophe | EVP, AMEA | M - OptEx | $23.21 | +66.4K | 138.6K | +92% | +$1.54M |
| DM | 2021-12-23 | 2021-12-21+ | AVTR | Couturier Christophe | EVP, AMEA | S - Sale+OE | $41.22 | -66.4K | 110.5K | -38% | -$2.74M |
| 2021-12-17 | 2021-05-14 | AVTR | Kang Lan | Dir | A - Grant | $0.00 | +4,022 | 4,022 | New | $0 | |
| 2021-12-17 | 2021-07-15 | AVTR | Carethers John | Dir | A - Grant | $0.00 | +2,565 | 2,565 | New | $0 | |
| DM | 2021-12-10 | 2021-12-08+ | AVTR | Couturier Christophe | EVP, AMEA | M - OptEx | $17.67 | +13.7K | 116.3K | +13% | +$241.8K |
| DM | 2021-12-10 | 2021-12-08+ | AVTR | Couturier Christophe | EVP, AMEA | S - Sale+OE | $40.14 | -13.7K | 110.5K | -11% | -$549.4K |
| 2021-12-03 | 2021-12-01 | AVTR | GUPTA RAJIV | Dir | S - Sale | $39.30 | -100.0K | 879.3K | -10% | -$3.93M | |
| DM | 2021-11-15 | 2021-11-11+ | AVTR | Vanderhaegen Frederic | EVP, Europe | S - Sale+OE | $38.32 | -140.8K | 154.5K | -48% | -$5.40M |
| D | 2021-11-15 | 2021-11-12 | AVTR | Vanderhaegen Frederic | EVP, Europe | M - OptEx | $23.20 | +80.0K | 234.5K | +52% | +$1.86M |
| 2021-11-10 | 2021-11-08 | AVTR | Massaro Joseph R | Dir | A - Grant | $0.00 | +745 | 745 | New | $0 | |
| 2021-11-02 | 2021-11-01 | AVTR | GUPTA RAJIV | Dir | S - Sale | $40.31 | -100.0K | 979.3K | -9% | -$4.03M | |
| 2021-11-01 | 2021-10-28 | AVTR | Murthy Mala | Dir | A - Grant | $0.00 | +916 | 916 | New | $0 | |
| 2021-10-04 | 2021-10-01 | AVTR | GUPTA RAJIV | Dir | S - Sale | $39.94 | -100.0K | 1.08M | -8% | -$3.99M | |
| 2021-09-22 | 2021-09-20 | AVTR | Stubblefield Michael | Pres, CEO, Dir | S - Sale | $42.37 | -141.3K | 1.26M | -10% | -$5.99M | |
| 2021-09-02 | 2021-09-01 | AVTR | GUPTA RAJIV | Dir | S - Sale | $39.45 | -100.0K | 1.18M | -8% | -$3.95M | |
| 2021-08-27 | 2021-08-26 | AVTR | Eck Steven W | SVP, CAO | S - Sale | $40.08 | -17.4K | 14.1K | -55% | -$696.7K | |
| 2021-08-23 | 2021-08-20 | AVTR | GUPTA RAJIV | Dir | S - Sale | $38.81 | -100.0K | 1.28M | -7% | -$3.88M | |
| I | 2021-08-13 | 2021-07-12 | AVTR | Natauri Jo | Dir | P - Purchase | $36.33 | +300 | 557.7K | +0.1% | +$10.9K |
| D | 2021-08-02 | 2021-07-30 | AVTR | Brophy Gerard | EVP, Biopharma Production | S - Sale+OE | $37.24 | -81.1K | 149.4K | -35% | -$3.02M |
| D | 2021-08-02 | 2021-07-30 | AVTR | Brophy Gerard | EVP, Biopharma Production | M - OptEx | $23.20 | +81.1K | 230.5K | +54% | +$1.88M |
| 2021-07-21 | 2021-07-20 | AVTR | Bramwell James | EVP, Strategic Partners | S - Sale | $37.00 | -6,112 | 79.9K | -7% | -$226.1K | |
| M | 2021-07-13 | 2021-07-09 | AVTR | Bramwell James | EVP, Strategic Partners | S - Sale | $35.61 | -18.3K | 98.2K | -16% | -$652.8K |
Purchase Sale Sale after option exercise All abbreviations